Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.

Stomper, Julia; Rotondo, John Charles; Greve, Gabriele; Lübbert, Michael

Stomper, Julia; Rotondo, John Charles; Greve, Gabriele; Lübbert, Michael.

Afiliação

Stomper J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Rotondo JC; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Greve G; Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Leukemia ; 35(7): 1873-1889, 2021 07.

Article em En | MEDLINE | ID: mdl-33958699

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Metilação de DNA/efeitos dos fármacos; Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos; Leucemia Mieloide Aguda/tratamento farmacológico; Síndromes Mielodisplásicas/tratamento farmacológico; Animais; Humanos; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Metilação de DNA Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google